EDITORIAL
Published on 17 Mar 2021
Editorial: FDA-Approved Drug Repositioning for P-Glycoprotein Overexpressing Resistant Cancer
doi 10.3389/fonc.2021.632657
- 1,503 views
- 6 citations
15k
Total Downloads
96k
Total Views and Downloads
Select the journal/section where you want your idea to be submitted:
EDITORIAL
Published on 17 Mar 2021
REVIEW
Published on 16 Nov 2020
REVIEW
Published on 26 Oct 2020
ORIGINAL RESEARCH
Published on 13 Aug 2020
MINI REVIEW
Published on 02 Jun 2020
ORIGINAL RESEARCH
Published on 12 May 2020
ORIGINAL RESEARCH
Published on 23 Apr 2020
REVIEW
Published on 05 Mar 2020
Frontiers in Pharmacology